4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-19-000156
Director sold 16,024 shares at an average $24.80 ($397,373)
- Director acquired 9,127 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HIPP RAYMOND R · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-23 | Exercise or conversion : show line 1 in the form | +3,017 | $11.60 | $34,997 | 144,016 | D |
| 2019-08-23 | Exercise or conversion : show line 2 in the form | +3,333 | $7.27 | $24,231 | 147,349 | D |
| 2019-08-23 | Exercise or conversion : show line 3 in the form | +2,777 | $9.11 | $25,298 | 150,126 | D |
| 2019-08-23 | Sale : show line 4 in the form | −600 | $25.02 | $15,012 | 149,526 | D |
| 2019-08-26 | Sale : show line 5 in the form | −15,424 | $24.79 | $382,361 | 134,102 | D |
| Open-market sales · 16,024 sh · avg $24.80 · $397,373 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-08-23 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,777 | $9.11 | 2021-07-28 | 2,777 | 0 | D |
| 2019-08-23 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,333 | $7.27 | 2022-05-25 | 6,667 | 3,334 | D |
| 2019-08-23 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,017 | $11.60 | 2023-06-01 | 3,017 | 0 | D |
Loading xslF345X03/wf-form4_156694223006156.xml…